MoonLake Immunotherapeutics

MoonLake Immunotherapeutics

NNASDAQ:MLTX
11.56
USD
-0.14
(-1.20%)
-3.84EPS
1.63BMarket Cap
Nov 17Next Earn

MoonLake Immunotherapeutics Documents

Q2 FY2023 · Presentation

MoonLake Immunotherapeutics - CMD 2023 - Conference Call Deck · 71 pages

Read MoonLake Immunotherapeutics's results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q2 FY2023 documents